12107203

Regnier C

2002

Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma.

12107215

Battaglia C

2002

Isolated premature pubarche: ultrasonographic and color Doppler analysis--a longitudinal study.

12107238

Kelly CJ

2002

A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome.

12112959

Schroeder B

2001

Early diagnosis, presenting complaints, and management of hyperandrogenism in adolescents.

12112963

Lathi RB

2001

Recombinant gonadotropins.

12116319

Abou-Sleiman PM

2002

First application of preimplantation genetic diagnosis to neurofibromatosis type 2 (NF2).

12122167

Bauer J

2002

Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.

12128286

Norman RJ

2002

The role of lifestyle modification in polycystic ovary syndrome.

12133398

Zheng Z

2002

[Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome].

12136394

Sir-Petermann T

2002

Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome.

12137881

Farquhar CM

2002

A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome.

12140666

Luef G

2002

Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.

12146151

Kacem M

2002

[Feminine pseudo-hermaphroditism and ovarian polycystic syndrome: the role of hydrocortisone].

12148236

Goldenstein S

2002

[Polycystic ovary. The PCO syndrome].

12148471

Carranza-Lira S

2002

[Ultrasonographic and lipid changes in polycystic ovary syndrome according to the type of treatment ].

12150695

Glueck CJ

2002

Treatment of polycystic ovary syndrome with insulin-lowering agents.

12151419

Nestler JE

2002

Should patients with polycystic ovarian syndrome be treated with metformin?: an enthusiastic endorsement.

12151427

Child TJ

2002

Basal serum levels of FSH and estradiol in ovulatory and anovulatory women undergoing treatment by in-vitro maturation of immature oocytes.

12151433

Amer SA

2002

Long term follow-up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: clinical outcome.

12151861

Kuller LH

2002

Hyperlipidaemia and cardiovascular disease.

12153742

Garcia-Rudaz MC

2002

Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome.

12153743

Kelly CJ

2002

The effect of metformin on hirsutism in polycystic ovary syndrome.

12161525

Yildiz BO

2002

Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state.

12161543

Gonzalez A

2002

Comment: CAPN10 alleles are associated with polycystic ovary syndrome.

12161545

Peral B

2002

Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.

12170391

Asconap? JJ

2002

Some common issues in the use of antiepileptic drugs.

12170870

Radulovi? A

2002

[Menstrual cycle disorders in polycystic ovary syndrome--ultrasonographic characteristics and hormonal status].

12182446

Kyono K

2002

Successful delivery following cryopreservation of zygotes produced by in vitro matured oocytes retrieved from a woman with polycystic ovarian syndrome-like disease: a case report.

12184121

Martikainen H

2001

[When and how should polycystic ovary syndrome be treated?].

12185760

Betts T

2002

Epilepsy and the ovary (cutting out the hysteria).

12185761

Betts T

2002

Case reports.

12192894

Loverro G

2002

Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.

12193950

Jones GL

2002

Health-related quality of life measurement in women with common benign gynecologic conditions: a systematic review.

12196859

Awartani KA

2002

Metformin and polycystic ovary syndrome: a literature review.

12199044

Jonard S

2002

[Polycystic ovary syndrome: recent genetic contributions].

12201826

Wijeyaratne CN

2002

Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?

12202405

Balen A

2002

What is polycystic ovary syndrome? Are national views important?

12202407

Seli E

2002

Should patients with polycystic ovarian syndrome be treated with metformin?

12202445

De Leo V

2002

Metformin and FSH for induction of ovulation in women with polycystic ovarian syndrome.

12202449

Pan HA

2002

Quantification of Doppler signal in polycystic ovarian syndrome using 3D power Doppler ultrasonography.

12213851

Azziz R

2002

Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling.

12213853

Li M

2002

Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators.

12213875

Van Dam EW

2002

Low amplitude and disorderly spontaneous growth hormone release in obese women with or without polycystic ovary syndrome.

12213887

Ehrmann DA

2002

Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome.

12215305

Leclair C

2002

Advances in polycystic ovary syndrome treatment: metformin and ovarian diathermy.

12215320

Sanders EB

2002

Inter- and intrafamilial variability in premature pubarche and polycystic ovary syndrome.

12215321

Remsberg KE

2002

Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome.

12215335

Legro RS

2002

Molecular progress in infertility: polycystic ovary syndrome.

12215362

Goldstein DB

2002

Clomid versus metformin for ovulation induction--let's not have any hanging chads!

12218667

Pritts EA

2002

Treatment of the infertile patient with polycystic ovarian syndrome.

12224658

Dietz WH

1998

Health consequences of obesity in youth: childhood predictors of adult disease.

12226928

Lytvak OO

2002

[Ultrastructure of the ovaries of patients with polycystic ovarian syndrome].

12229282

Vel?squez E

2002

[Chronic complications of polycystic ovary syndrome. Review].

12230452

Ajossa S

2002

Hyperinsulinemia and uterine perfusion in patients with polycystic ovary syndrome.

12232991

Koivunen R

2002

[Insulin resistance and infertility].

12233944

Slocum JM

2002

Use of antidiabetes agents in pregnancy: current practice and controversy.

12238006

Hippel?inen M

2002

[Polycystic ovarian syndrome is a health risk].

12265004

Botella-llusia J

1979

The polycystic ovary syndrome (a reappraisal).

12269862

Perucca E

2002

Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

12271740

Trent M

2002

Adolescent obesity: identifying a new group of at-risk youth.

12279395

Molitch ME

1979

Management of post-pill amenorrhea.

12282188

Belaisch J

1988

[Oral contraception and its beneficial gynecological effects].

12351518

Homburg R

2002

What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome.

12351525

Cheung AP

2002

In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome.

12351531

Sir-Petermann T

2002

Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization.

12356937

Sudo S

2002

Genetic and functional analyses of polymorphisms in the human FSH receptor gene.

12358558

Shaw JC

2002

Acne: effect of hormones on pathogenesis and management.

12360633

Samraj GP

2002

Polycystic ovary syndrome [PCOS]: comprehensive management in primary care.

12364425

Randeva HS

2002

Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome.

12364431

Bagis T

2002

The effects of short-term medroxyprogesterone acetate and micronized progesterone on glucose metabolism and lipid profiles in patients with polycystic ovary syndrome: a prospective randomized study.

12364442

Sch?fl C

2002

Circulating ghrelin levels in patients with polycystic ovary syndrome.

12364451

Silfen ME

2002

5 alpha-reductase and 11 beta-hydroxysteroid dehydrogenase activity in prepubertal Hispanic girls with premature adrenarche.

12367820

Davies MJ

2002

Programming and reproductive functioning.

12369659

Andrejevic S

2002

Intracardiac thrombosis and fever possibly triggered by ovulation induction in a patient with antiphospholipid antibodies.

12370108

Colak R

2002

A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.

12372486

Morelli EM

2002

Metformin and BMI?

12380199

Dawber RP

2002

Hirsuties.

12383531

Child TJ

2002

A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries.

12396555

Korhonen S

2002

Lack of association between C-850T polymorphism of the gene encoding tumor necrosis factor-alpha and polycystic ovary syndrome.

12396556

Falsetti L

2002

Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences.

12396891

Dunaif A

2002

Toward optimal health: the experts discuss polycystic ovary syndrome.

12397915

Carcio H

2000

Polycystic ovarian syndrome. Preventing long-term health effects.

12398222

Simoni M

2002

Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction.

12398225

Homburg R

2002

Ovulation induction in perspective.

12400319

Robinson K

2001

'Off-label' use of metformin warranted.

12401970

Stafford DE

2002

Adolescent androgen abnormalities.

12407038

Amer SA

2002

Long-term follow-up of patients with polycystic ovary syndrome after laparoscopic ovarian drilling: endocrine and ultrasonographic outcomes.

12407039

Glueck CJ

2002

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin.

12407057

Son WY

2002

Ongoing twin pregnancy after vitrification of blastocysts produced by in-vitro matured oocytes retrieved from a woman with polycystic ovary syndrome: Case report.

12407071

Yarali H

2002

Metformin and FSH for induction of ovulation in women with polycystic ovary syndrome.

12410375

Furuhashi M

2002

Successful pregnancy in a patient having high basal serum levels of sex steroid hormones.

12413983

Guido M

2002

Effect of the opioid blockade on the feeding-induced growth hormone response to growth hormone-releasing hormone in women with polycystic ovary syndrome.

12413984

Parsanezhad ME

2002

Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: a prospective, double-blind, placebo-controlled trial.

12416047

Luttrull S

2001

Be wary of recommending off-label use of meds.

12416048

Sonnenstuhl P

2001

More on PCOS.

12418063

Takeuchi S

2002

Polycystic ovary syndrome treated with laparoscopic ovarian drilling with a harmonic scalpel. A prospective, randomized study.

12419034

Stadtmauer LA

2002

Impact of metformin therapy on ovarian stimulation and outcome in 'coasted' patients with polycystic ovary syndrome undergoing in-vitro fertilization.

12422580

Salobir B

2002

Basal glucose level as an independent predictor of fertilization rate in patients without polycystic ovary syndrome included in an in-vitro fertilization program.

12423835

Olufowobi O

2002

Spontaneous disappearance of a normal adnexa associated with a contralateral polycystic-appearing ovary.

12424081

Tettenborn B

2002

Epilepsy and women's issues: an update.